Atara Biotherapeutics, Inc. (ATRA)
NASDAQ·Healthcare·Biotechnology
$8.70
+1.75%
Mkt Cap $40.81M
Analyst Ratings
Buy
1
Hold
1
Sell
0
Price Target (7 analysts)
$9.50
Range $6.00 – $13.00
Implied Upside
+9.2%
Consensus $9.50 vs current $8.70
NASDAQ·Healthcare·Biotechnology
$8.70
+1.75%
Mkt Cap $40.81M
Buy
1
Hold
1
Sell
0
Price Target (7 analysts)
$9.50
Range $6.00 – $13.00
+9.2%
Consensus $9.50 vs current $8.70